Genetic Signatures Liabilities 2024

Liabilities Details

Assessing Genetic Signatures's Liabilities

Genetic Signatures's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Genetic Signatures's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Genetic Signatures's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Genetic Signatures's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Genetic Signatures’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Genetic Signatures Stock

What is the level of liabilities of Genetic Signatures this year?

Genetic Signatures has a debt balance of 6.16 M AUD this year.

What were the liabilities of Genetic Signatures compared to the previous year?

The liabilities of Genetic Signatures have increased by 27.04% increased compared to the previous year.

What are the consequences of high debt for investors of Genetic Signatures?

High liabilities can pose a risk for investors of Genetic Signatures, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Genetic Signatures?

Low liabilities mean that Genetic Signatures has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Genetic Signatures affect the company?

An increase in liabilities of Genetic Signatures can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Genetic Signatures affect the company?

A decrease in the liabilities of Genetic Signatures can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Genetic Signatures?

Some factors that can influence the liabilities of Genetic Signatures include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Genetic Signatures so important for investors?

The liabilities of Genetic Signatures are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Genetic Signatures take to modify the liabilities?

To change its liabilities, Genetic Signatures can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Genetic Signatures pay?

Over the past 12 months, Genetic Signatures paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genetic Signatures is expected to pay a dividend of 0 AUD.

What is the dividend yield of Genetic Signatures?

The current dividend yield of Genetic Signatures is .

When does Genetic Signatures pay dividends?

Genetic Signatures pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genetic Signatures?

Genetic Signatures paid dividends every year for the past 0 years.

What is the dividend of Genetic Signatures?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genetic Signatures located?

Genetic Signatures is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genetic Signatures kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genetic Signatures from 6/26/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Genetic Signatures pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Genetic Signatures in the year 2023?

In the year 2023, Genetic Signatures distributed 0 AUD as dividends.

In which currency does Genetic Signatures pay out the dividend?

The dividends of Genetic Signatures are distributed in AUD.